Title  | Date  | Price  |
|---|
Slovakia Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Canada Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Iran Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Australia Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Germany Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Lebanon Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Latvia Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Jordan Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
US Publishing Sector: Industry Profile
| Jun 2009 |
£365 |
Greece Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Croatia Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Pakistan Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Nigeria Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Bangladesh Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Kenya Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Zimbabwe Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
Thailand Pharmaceuticals and Healthcare Report Q3 2009
| Jun 2009 |
£250 |
India Pharmaceuticals Report Q2 2009
| May 2009 |
£250 |
Kazakhstan Pharmaceuticals and Healthcare Report Q2 2009
| May 2009 |
£250 |
Bahrain Pharmaceuticals and Healthcare Report Q2 2009
| May 2009 |
£250 |
Ten Canadian Healthcare Solutions to Watch
| May 2009 |
£2,135 |
The Indian Pharmaceutical Industry 2009 Diversification, Expansion & Ambitions
| May 2009 |
£995 |
Venezuela Pharmaceuticals and Healthcare Report Q2 2009
| May 2009 |
£250 |
Puerto Rico Pharmaceuticals and Healthcare Report Q2 2009
| May 2009 |
£250 |
Russia Pharmaceuticals and Healthcare Report Q2 2009
| May 2009 |
£250 |
Ukraine Pharmaceuticals and Healthcare Report Q2 2009
| May 2009 |
£250 |
South Korea Pharmaceuticals and Healthcare Report Q2 2009
| May 2009 |
£250 |
South and Central American Pharmaceutical Directory 2008 / 2009
| May 2009 |
£155 |
Perspective: Western Europe, Healthcare Sector Pulse, July-September 2008
| Apr 2009 |
£915 |
Healthcare Industry in India-2009
| Apr 2009 |
£610 |
Snapshots Sweden Pharmaceuticals 2009
| Apr 2009 |
£300 |
The Pharmaceutical Market: India
| Apr 2009 |
£595 |
Serbia Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Snapshots Japan Pharmaceuticals 2009
| Apr 2009 |
£300 |
Snapshots Ukraine Pharmaceuticals 2009
| Apr 2009 |
£300 |
Peru Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Healthcare Industry in China-2009
| Apr 2009 |
£610 |
Poland Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Taiwan Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Spain Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Pakistan Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
The Pharmaceutical Market: Sweden
| Apr 2009 |
£595 |
Slovenia Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Snapshots Russia Pharmaceuticals 2009
| Apr 2009 |
£300 |
Indonesia Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Czech Republic Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Snapshots Argentina Pharmaceuticals 2009
| Apr 2009 |
£300 |
Egypt Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Colombia Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
The Pharmaceutical Market: Czech Republic
| Apr 2009 |
£595 |
Belgium Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Italy Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Chile Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Nigeria Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Pharmaceuticals in Germany Pharmaceuticals
| Apr 2009 |
£155 |
Thailand Pharmaceuticals and Healthcare Report Q2 2009
| Apr 2009 |
£250 |
Pharmaceutical Markets in India
| Apr 2009 |
£790 |
The Pharmaceutical Market: Malaysia
| Apr 2009 |
£595 |
Indian Pharmaceutical Industry - SWOT Framework Analysis
| Apr 2009 |
£120 |
Pharmaceutical Industry in India - PEST Framework Analysis
| Apr 2009 |
£145 |
Pharmaceutical Industry in China: PEST Framework Analysis
| Apr 2009 |
£305 |
Pharmaceutical Industry in Mexico
| Apr 2009 |
£335 |
Analyzing the Indian Pharmaceutical Industry
| Apr 2009 |
£335 |
Pharmaceutical Directory of China 2009
| Apr 2009 |
£155 |
Canada Pharmaceutical Industry
| Apr 2009 |
£730 |
Pharmaceutical Industry in India - Porter's Five Forces Strategy Analysis
| Apr 2009 |
£155 |
Drug Industry in the United States: Porter's Five Forces Strategy Analysis
| Apr 2009 |
£155 |
Pharmaceutical Industry in the United States: Porter's Five Forces Strategy Analysis
| Apr 2009 |
£155 |
Pharmaceutical Industry in the United States
| Apr 2009 |
£365 |
US Pharmaceutical Industry: PEST Framework Analysis
| Apr 2009 |
£145 |
Pharmaceutical Industry in UK: Porter's Five Forces Strategy Analysis
| Apr 2009 |
£155 |
Pharmaceutical Industry in China
| Apr 2009 |
£915 |
China's Pharmaceutical Industry: Porter's Five Forces Strategy Analysis
| Apr 2009 |
£155 |
Canada's Pharmaceutical Industry: Porter's Five Forces Strategy Analysis
| Apr 2009 |
£155 |
Global Pharmaceuticals
| Mar 2009 |
£155 |
Pharmaceuticals in Russia
| Mar 2009 |
£155 |
Pharmaceuticals in Italy
| Mar 2009 |
£155 |
Pharmaceuticals in Asia-Pacific
| Mar 2009 |
£155 |
Pharmaceuticals in Belgium
| Mar 2009 |
£155 |
Pharmaceuticals in the Czech Republic
| Mar 2009 |
£155 |
Pharmaceuticals in Japan
| Mar 2009 |
£155 |
Pharmaceuticals in Canada
| Mar 2009 |
£155 |
The Canadian Pharmaceutical Market Outlook to 2013: Policy environment, market structure, pipeline analysis, growth opportunities Healthcare
| Mar 2009 |
£2,025 |
The Asian Cardiovascular Market Outlook to 2014: Regional and therapeutic analysis, pipeline impact and growth opportunities Healthcare
| Mar 2009 |
£2,025 |
Pharmaceuticals in France
| Mar 2009 |
£155 |
Pharmaceuticals in Norway
| Mar 2009 |
£155 |
Pharmaceuticals in Poland
| Mar 2009 |
£155 |
Pharmaceuticals in the United States
| Mar 2009 |
£155 |
Pharmaceuticals in the United Kingdom
| Mar 2009 |
£155 |
Pharmaceuticals in the Netherlands
| Mar 2009 |
£155 |
Pharmaceuticals in Spain
| Mar 2009 |
£155 |
Pharmaceuticals in Mexico
| Mar 2009 |
£155 |
Pharmaceuticals in Brazil
| Mar 2009 |
£155 |
Pharmaceuticals in South Korea
| Mar 2009 |
£155 |
Pharmaceuticals in Sweden
| Mar 2009 |
£155 |
Pharmaceuticals in Denmark
| Mar 2009 |
£155 |
Pharmaceuticals in South Africa
| Mar 2009 |
£155 |
Pharmaceuticals in India
| Mar 2009 |
£155 |